Welcome & introduction (ID 4709)
Moving forward in the treatment of endocrine-sensitive HR+/HER2– aBC (ID 4710)
Building confidence in the treatment of challenging populations in endocrine-resistant HR+/HER2– aBC (ID 4711)
Increasing clarity in diagnosing and treating germline BRCA-mutated aBC (ID 4712)
Q&A and discussion (ID 4713)
